Primary Record
Sapanisertib
- In stock
- 3,254 g
- Purity
- 98.5 %
- CAS
- 1224844-38-5
Compound Identifiers & Properties
- CAS
- 1224844-38-5
- PubChem CID
- 45375953
- SMILES
- CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N
- Canonical SMILES
- CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21
Names & Synonyms
- Sapanisertib
- 1224844-38-5
- INK-128
- MLN0128
- INK128
- sapanisertibum
- INK 128
- Sapanisertib [INN]
- TAK-228
- MLN-0128
- Sapanisertib (MLN0128)
- INK 128 (MLN0128)
- JGH0DF1U03
- RefChem:58086
- UNII-JGH0DF1U03
- MFCD22124893
- Sapanisertib (USAN/INN)
- Sapanisertib [USAN:INN]
- D03DPZ
- SAPANISERTIB [USAN]
- INK-128(Sapanisertib)?
- CB-228
- C15H15N7O
- MLS006011012
- SAPANISERTIB [WHO-DD]
- 5-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)benzo[d]oxazol-2-amine
- DTXSID401022538
- GTPL7933
- orb1307349
- SCHEMBL7902875
- CHEMBL3545097
- SCHEMBL29351459
- CHEBI:91450
- EX-A951
- INK-128/INK128
- SYN1157
- BDBM315477
- DTXCID201507223
- GLXC-90200
- HMS3656H12
- HMS3672C21
- INK-128;Sapanisertib;MLN0128
- AOB87177
- INK-0128
- 2477AH
- NSC764658
- NSC768435
- NSC780880
- s2811
- ZINC73069271
- AKOS025149512
- US10172858, Table 1.1
- BCP9000789
- CCG-265002
- CS-0557
- DB11836
- NSC-764658
- NSC-768435
- NSC-780880
- SB16566
- SDCCGSBI-0646935.P002
- INK 128; MLN 0128; Sapanisertib
- US10172858, Table 1.22
- NCGC00346654-01
- NCGC00346654-10
- AC-26848
- AK175515
- AS-16294
- BS170924
- CID:45375953
- HY-13328
- SMR004702810
- SY122459
- BCP0726000086
- SID:310264841
- 3-(2-Amino-5-benzoxazolyl)-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- DB-293450
- A8551
- FT-0700125
- NS00072976
- SW220210-1
- J3.052.643K
- KS-00000633
- A11461
- D11183
- Sapanisertib (NK128; MLN0128; TAK228)
- W-5898
- 5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine
- 1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 3-(2-amino-5-benzoxazolyl)-1-(1-methylethyl)-
- A899013
- C572449
- INK-128,CAS:1224844-38-5
- BRD-K59317601-001-05-5
- Q27078072
- 2-Benzoxazolamine, 5-(4-amino-1-(1-methylethyl)-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-
- 3-(2-Amino-1,3-benzoxazol-5-yl)-1-isopropyl-1H-pyrazolo(3,4-d)pyrimidin-4-amine
- 5-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]-pyrimidin-3-yl)benzo[d]oxazol-2-amine
- B2693-453595
- 3-(2-aminobenzo[d]oxazol-5-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- 5-(4-amino-1-isopropyl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine
- 5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine
- Sapanisertib, 98%, a potent and selective mTOR inhibitor - 10MG 10mg
- 1-Isopropyl-4-amino-3-(2-aminobenzoxazole-5-yl)-1H-pyrazolo[3,4-d]pyrimidine
- 3-(2-Amino-1,3-benzoxazol-5-yl)-1-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- 3-(2-Amino-5-benzoxazolyl)-1-(1-methylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine
- 5-(4-amino-1-(propan-2-yl)-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-1,3-benzoxazol-2-amine
- 5-(4-amino-1-propan-2-ylpyrazolo(3,4-d)pyrimidin-3-yl)-1,3-benzoxazol-2-amine
- 5-[4-amino-1-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-1,3-benzoxazol-2-amine
- 1H-PYRAZOLO(3,4-D)PYRIMIDIN-4-AMINE, 3-(2-AMINO-5-BENZOXAZOLYL)-1-(1-METHYLETHYL)-
- FE5
- INK-128|||MLN-0128|||5-(4-Amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine